Esperion Therapeutics
ESPR
#6169
Rank
HK$6.88 B
Marketcap
HK$29.04
Share price
-1.58%
Change (1 day)
11.72%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -HK$0.22 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are HK$0.30 Billion. In 2024 the company made an earning of HK$58.43 Million, an increase over its 2023 earnings that were of -HK$1.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.22 Billion-464.32%
2024 HK$58.43 M-104.99%
2023 -HK$1.17 Billion-15.03%
2022 -HK$1.38 Billion-20.61%
2021 -HK$1.74 Billion84.28%
2020 -HK$0.95 Billion35.75%
2019 -HK$0.7 Billion-55.71%
2018 -HK$1.57 Billion19.57%
2017 -HK$1.31 Billion125.39%
2016 -HK$0.59 Billion51.43%
2015 -HK$0.39 Billion36.45%
2014 -HK$0.29 Billion43.55%
2013 -HK$0.2 Billion145.26%
2012 -HK$79.84 Million
2002 -HK$0.23 Billion-7.81%
2001 -HK$0.25 Billion15.03%
2000 -HK$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-HK$4.04 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$5.28 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.26 B-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$40.05 B-18,849.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$38.78 M-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-HK$0.54 Billion 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA